NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference

Saturday, March 1, 2008 General News J E 4
BEDMINSTER, N.J., Feb. 29 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., executive vicepresident, chief operating officer, and chief executive officer-elect isscheduled to present at the Lehman Brothers Eleventh Annual Global HealthcareConference in Miami on Wednesday, March 19, 2008 at 3:15 p.m. ET. Thepresentation will be available as a live webcast with a replay availableapproximately 24 hours after the presentation has concluded. Interestedparties may access the webcast from the NPS website,

About NPS Pharmaceuticals

NPS Pharmaceuticals is developing high value specialty therapeutics forgastrointestinal and endocrine disorders. The company is currently advancingtwo late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinicaldevelopment for intestinal failure associated with short bowel syndrome andparathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinicaldevelopment as a hormone therapy for hypoparathyroidism. NPS has alsocompleted a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84[rDNA origin] injection). NPS complements its internal programs withstrategic partnerships, which include Amgen, GlaxoSmithKline, Kirin, andNycomed. Additional information is available at

SOURCE NPS Pharmaceuticals, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
African American Health Disparities
Smith & Nephew Orthopaedic Reconstruction Global M...